One contribution of 16 to a discussion meeting issue 'Release of chemical transmitters from cell bodies and dendrites of nerve cells'.
Papers in this issue concern extrasynaptic transmission, namely release of signalling molecules by exocytosis or diffusion from neuronal cell bodies, dendrites, axons and glia. Problems discussed concern the molecules, their secretion and importance for normal function and disease. Molecules secreted extrasynaptically include transmitters, peptides, hormones and nitric oxide. For extrasynaptic secretion, trains of action potentials are required, and the time course of release is slower than at synapses. Questions arise concerning the mechanism of extrasynaptic secretion: how does it differ from the release observed at synaptic terminals and gland cells? What kinds of vesicles take part? Is release accomplished through calcium entry, SNAP and SNARE proteins? A clear difference is in the role of molecules released synaptically and extrasynaptically. After extrasynaptic release, molecules reach distant as well as nearby cells, and thereby produce long-lasting changes over large volumes of brain. Such changes can affect circuits for motor performance and mood states. An example with clinical relevance is dyskinesia of patients treated with L-DOPA for Parkinson's disease. Extrasynaptically released transmitters also evoke responses in glial cells, which in turn release molecules that cause local vasodilatation and enhanced circulation in regions of the brain that are active.
Aims of this special issue of Philosophical Transactions of the Royal Society
The papers collected here present an overview of the mechanism and functional importance of release from 'extrasynaptic' sites. A major objective of this Royal Society special issue was to promote discussion by people who use cellular, molecular and physiological techniques to study the release of transmitters, peptides and hormones from neuronal cell bodies, dendrites and glial cells. A further aim is to analyse the differences and similarities between exocytosis from synapses and gland cells. A great deal of modern research has been devoted to understanding transmitter release by presynaptic terminals. Most general knowledge about the mechanism of transmitter release has come from experiments on neuromuscular junctions [1] and the squid giant synapse ( [2] ; for review, see [3, 4] ), and more recently from synapses formed by neurons in culture, first obtained between adult leech neurons [5] and afterwards between other neuron types. Yet, paradoxically, axon varicosities of parasympathetic nerve axons and chromaffin cells in the adrenal medulla are sites of extrasynaptic release at which chemically mediated synaptic transmission was postulated for the first time in 1921 by Loewi [6] and in 1904 by Elliot [7] . Papers in this collection show that release from neuronal and glial cell bodies, dendrites and axons is widespread. It represents a novel area of research on functional changes in the input-output relationships of the nervous system that last for days, weeks or months. A feature of 'extrasynaptic' release, in addition to its prolonged time course, is the widespread transmission of signalling molecules to distant structures. One key problem dealt with in this issue concerns the mechanisms by which neurons, glia and gland cells give rise to extrasynaptic secretion. What are the similarities to and differences from the way in which secretion occurs from presynaptic & 2015 The Author(s) Published by the Royal Society. All rights reserved.
nerve terminals? In conventional synapses, transmission is fast, and the transmitter acts for milliseconds to seconds on post-and also presynaptic targets [1, 8] . At presynaptic nerve terminals short-term plasticity lasting for seconds, minutes or hours is evident as facilitation, depression and post-tetanic potentiation of release [9, 10] . By contrast, long-term changes in the efficacy of transmission are caused for the most part by postsynaptic mechanisms, involving NMDA [11] and metabotropic receptors [12, 13] . Release from neuronal cell bodies and dendrites gives rise to maintained transmitter concentrations in the extracellular spaces of not only near, but also distant neurons, glial cells and blood vessels [14] . Accordingly, a second major objective of papers presented here was to analyse how extrasynaptic release can influence integrative functions of the nervous system, behaviour and disease. Examples are provided by long-term effects of transmission, (i) on integrative mechanisms in the central nervous system, (ii) on glial regulation of blood flow through the brain, and (iii) on motor performance in patients with Parkinson's disease and on higher functions of the brain.
Problems tackled by papers in this issue
(a) Comparison of mechanisms for synaptic and extrasynaptic exocytosis of serotonin, dopamine, noradrenaline and peptides
Far less is known about extrasynaptic secretion than about transmitter release by presynaptic nerve terminals or gland cells. For example, the time course and magnitude of transmitter release have been measured with extraordinarily high resolution in motoneuron terminals, thanks to the occurrence of miniature endplate potentials and by the measurement of ion currents that occur in the receptors of the postsynaptic muscle membrane [15] . Thus, reliable estimates have been made of the number of acetylcholine molecules in a small (40-50 nm diameter) clear vesicle [16] , the timing of calcium in the presynaptic membrane [17] , the molecular mechanisms for docking and fusion [18, 19] and the number of vesicles that release transmitter per impulse [20] . A major advance is that one can observe presynaptic steps in the release mechanism by electron microscopic tomography [21] . Thin sections of a presynaptic terminal at motor nerve endings have been tilted through more than 708 to allow three-dimensional reconstructions of terminals from electron microscopy sections of intracellular and membrane structures at subnanometre resolution, at rest or in response to impulse activity. Electron tomography allows one to reconstruct the molecular steps by which synaptic vesicles move towards, dock with the presynaptic plasma membrane and become fused. Docking is a precondition for the vesicle fusion with the presynaptic membrane and release of neurotransmitter into the synaptic cleft. Synaptic vesicles do not dock just anywhere, but only at a specialized region known as the 'active zone'. The active zone consists of aggregates of macromolecules that are attached to the cytosolic surface of the presynaptic membrane and to calcium channels. The highly ordered network of the active zone can be classified by the position and associations of distinct groups of macromolecules. One type of structure is connected to calcium channels in the presynaptic membrane close to the docked synaptic vesicles. Before a vesicle becomes docked, it moves towards the active zone. Membrane proteins of a vesicle that will interact with the active zone material must arrive in a characteristic arrangement determined by a radial assembly of macromolecules. As a result, in response to electrical stimulation, a specific region of the vesicle membrane-the fusion domain-is brought into direct contact with the presynaptic membrane. Vesicle fusion incorporates a stereotyped sequence of changes in the molecules of the active zone molecules and the vesicles. Open questions that remain bear on the problem of identifying these proteins and understanding how a docked vesicle becomes primed for fusion and transmitter release.
Release of transmitters and peptides from gland cells follows a different scheme. Molecules are contained in large (greater than 100 nm) electrondense vesicles [22] . Vesicle fusion requires longer-lasting depolarization than that required for release of synaptic clear vesicles [23] ; in addition, calcium entry occurs through different sets of channels [24] . In response to depolarization, electrondense vesicles in chromaffin cells are transported actively towards the plasma membrane where they fuse to produce exocytosis [25] . There is evidence that the activation volume of fusion complexes regulates the kinetics of exocytosis and therefore, the probability of its fusion with the plasma membrane. The role of the activation volume has been studied by applying hydrostatic pressure to chromaffin cells (see [26] ). The reaction and equilibrium kinetics of secretion have been measured as capacitance changes by use of the patch clamp technique. When pressures of up to 20 MPa (200 Atm) are presented, the changes in the kinetics of exocytosis can be explained in terms of interactions between the vesicles and proteins that cause exocytosis. The results indicate a similar activation volume of 390 + 57 Å 3 for large dense core vesicle fusion in chromaffin cells; the value is similar for the degranulation of mast cells. This information predicts protein conformational changes during the reactions involved in vesicle fusion. Extrasynaptic release of transmitters and peptides occurs in animals as different as leeches and mammals. Trains of impulses are required and exocytosis is maintained for long periods. Extrasynaptic release is accomplished differently from release at motorneuron terminals. Detailed studies of the steps between electrical activity and exocytosis have been made in central neurons releasing serotonin or oxytocin and vasopressin. Serotonin (5-hydroxy tryptamine, 5-HT) is an important transmitter in the central nervous systems of vertebrates and invertebrates, where it contributes to the modulation of multiple functions from development to disease. Malfunction of the serotonergic system may cause sudden death and many antidepressants act on its reuptake after release. Serotonin release from nerve terminals resembles that occurring at neuromuscular presynaptic terminals [27] . However, serotonin is also released from extrasynaptic sites, such as cell bodies and dendrites. Extrasynaptic release of serotonin has been studied by structural and physiological experiments made on cell bodies of Retzius neurons in the central nervous system of the leech (see [28] ). The large 80 mm diameter soma of a Retzius neuron contains numerous clusters of electrondense vesicles filled with serotonin. Electrical stimulation of the soma causes electrondense vesicles to move en masse to the cell surface without docking at an identifiable active zone. There they fuse and release serotonin for several minutes. Vesicle transport and release depend on the frequency of electrical stimulation. Unlike the serotonin rstb.royalsocietypublishing.org Phil. Trans. R. Soc. B 370: 20140181 release that occurs at synaptic terminals, single action potentials or trains at 1 Hz fail to evoke transport of vesicles to the cell membrane. By contrast, following trains of stimuli at 20 Hz, about 100 vesicle clusters move to different places on the plasma membrane, where they fuse. The exocytosis in which tens of thousands of vesicles release serotonin over periods of minutes is owing to a chain of intracellular events triggered by calcium entry. This in turn causes a wave of calcium-induced calcium release that seems to promote adenosine triphosphate (ATP) synthesis by mitochondria. ATP induces vesicle transport through kinesin motors coupled to microtubules. Serotonin that has been released acts on autoreceptors; these induce an IP3-dependent calcium increase in the soma, which produces further exocytosis. Thus, a positive feedback mechanism maintains exocytosis until the last vesicles in each cluster fuse and the calcium levels return to basal levels. Serotonin released from the soma acts on surrounding glial cells, which take it up and presumably transport it to other sites of the nervous system. Records of the electrical activity of neurons in the central nervous system of the leech show that stimulation of a Retzius cell can produce effects that last for several hours. Several lines of evidence show that extrasynaptic release of serotonin modulates the behaviour of the animal for prolonged periods [29] .
Dopamine is another transmitter that is released extrasynaptically. It plays a key role in motor and emotive pathways of the mammalian brain. Dysfunction of dopaminergic systems has been implicated in disorders that include Parkinson's disease, addiction and schizophrenia. In addition to exhibiting classical vesicular release of dopamine from their axon terminals, dopamine-containing midbrain neurons release the transmitter from their cell bodies and dendrites [30] . Axons of dopaminergic neurons in the brainstem project to the dorsal and ventral striatum and to the forebrain. Extrasynaptic release of dopamine is also calcium-dependent, although aspects of this dependence are not yet understood. The dopamine that has been released activates D2 autoreceptors in dopaminergic neurons themselves. This activates G-protein-coupled inwardly rectifying potassium channels. Therefore, the local increases in the extracellular dopamine concentration inhibit firing of the dopamine neurons. This local autoinhibition helps to determine the pattern of dopamine signalling at distant axonal release sites. Somatodendritic dopamine release also acts via volume transmission to modulate transmitter release and activity of other midbrain neurons. Hence, extrasynaptic release is a pivotal intrinsic feature of dopaminergic neurons that can play a part in our understanding of physiology, higher functions of the brain and its pathologies.
As with serotonin, the activity requirements for somatodendritic release of the neuropeptides vasopressin and oxytocin are distinct from those for release by nerve terminals [31] . Thus, as expected, large electrondense vesicles in axonal terminals of the magnocellular neurons of the hypothalamic supraoptic nucleus and paraventricular nucleus fuse with high reliability following individual action potentials. By contrast, the fusion of electrondense vesicles in the soma requires sustained calcium elevation; the actual fusion events are not locked to cell firing. The process is slower than synaptic release and depends on trains of impulses. Moreover, exocytosis in the dendrites can be evoked by calcium release from intracellular stores without any depolarization. Intracellular calcium release promotes 'priming' of the releasable pool of electrondense vesicles in dendrites and priming enhances activity-dependent release of oxytocin and vasopressin. This provides a feedforward mechanism that lasts tens of minutes. One can speculate that oxytocin and vasopressin act as hormone-like signals on distant brain targets. The slow prolonged action on specific peptide receptors has been shown to trigger a temporary functional reorganization of neuronal networks and thereby induce prolonged changes in behaviour.
The previous paragraphs have shown that neurons of vertebrates and invertebrates that release serotonin, dopamine or peptide hormones share similar mechanisms for exocytosis from their soma and dendrites. Open questions that remain concern the sites at which dense cored vesicles become docked on the membrane and the final steps and molecules that lead to fusion. A principal point of convergence between release at synaptic terminals and extrasynaptic release is the essential role of calcium.
The mechanisms for extrasynaptic exocytosis described above occur in the absence of closely apposed postsynaptic counterparts. Moreover, the lack of correlation between the release sites and the receptor localization has suggested that signalling molecules must reach their receptors via 'volume transmission' (see [32] ). In addition, there is now evidence that signalling molecules can reach their targets by the extracellular movement of vesicles released from neurons and glia through extracellular space [32] . Those vesicles can transfer lipids and proteins, including receptors, and GTPases, as well as subsets of mRNAs and non-coding regulatory micro-RNAs, to other cells located distantly. Such transport offers opportunities for long-term modulation of synaptic transmission and also for prion infection and mobilization of proteins that contribute to Alzheimer's disease. Another new area of research has shown that the formation of heterodymeric receptors adds complexity to the number of possible responses to a given transmitter molecule.
In this regard, catecholamines are released from the cell bodies of superior cervical ganglion neurons and from chromaffin cells in response to activation of nicotinic acetylcholine receptors. This release is activated by calcium entry across the pore of the acetylcholine receptor [33] . However, in both cell types, activation of muscarinic acetylcholine receptors reduces the mean open time of the nicotininc receptor pore. The effect of the muscarinic agonist requires time and acts to reduce the amount of calcium entry in response to delayed activations of the acetylcholine receptor. By doing this, activation of muscarinic receptors blocks exocytosis. The effect is mediated by G proteins with contributions of protein kinases A and C.
(b) Glia and extrasynaptic release
One of the first physiological properties of neuroglial cells to be defined was their coupling by electrical synapses [34] : the spread of current, ions and molecules from glial cell to glial cell allows glia to act as a sheet rather than as individuals. ATP is a transmitter molecule that is extrasynaptically secreted by neurons and glia [35] . Extracellular ATP serves as a signal for diverse physiological functions, some mediated by spread of calcium waves between astrocytes. In addition, ATP release from glia occurs through the Pannexin1 channel. This is a non-junctional membrane channel with a large conductance (500 pS) and unselective permeability to molecules of less than 1.5 kDa. The interaction between Pannexin 1 and ATP is intimate. The channel serves as the conduit for ATP efflux from cells along its concentration gradient. Control of ATP efflux is provided by ATP via two opposite effects. The Pannexin 1 channel itself is modulated by ATP through activation of ionotropic P2X receptors or metabotropic P2Y receptors. Hence, activation of an ATP release channel by ATP represents another positive feedback loop. This would lead to cell death in the absence of a control mechanism, because purinergic receptors are linked to apoptotic processes. However, the direct binding of ATP to the Pannexin1 protein prevents this death through closure of the channel.
Extracellular ATP produces calcium waves on neighbouring glial cells. ATP released from stimulated glial cells activates P2Y receptors, resulting in calcium release from internal stores. The calcium waves produced in this way flow from one glial cell to another through gap junctions. Calcium waves in glial cells are also generated by hydrogen peroxide, a reactive oxygen species present in glial cells. The propagation of calcium waves in hippocampal astrocytes is blocked by scavengers of reactive oxygen species.
Other molecules secreted by glial cells are growth factors. Exposure of glial cells to thyroid hormone causes them to release basic fibroblast growth factor and neurotrophin-3 [36] . These proteins increase the density of sodium currents in cultured hippocampal neurons. Similar increases in sodium current are produced by activated microglial cells and by tumour necrosis factor. Together, these findings suggest that release of growth factors from satellite cells can alter neuronal excitability over a time course of several days. It seems possible that growth factors secreted by glia might account for changes in neuronal excitability that occur in conditions of thyroid hormone imbalance. Important effects of extrasynaptic release of signalling molecules by glia are further considered in §2c.
(c) Effects of extrasynaptic transmission on functional activity of the central nervous system
The papers cited in this section show different ways in which transmitters liberated from extrasynaptic sites can have profound and long-lasting effects on integrative mechanisms of the nervous system. These examples include interactions between neurons, glial cells and blood vessels. At the cellular level, two different transmitters released extrasynaptically have opposite effects on the dendritic spiking of cortical neurons. Glutamate and ATP released extrasynaptically, most probably by glial cells, have been implicated in the regulation of the properties of dendritic spikes [37] . These spikes are produced upon activation of presynaptic inputs onto the dendrites. A combination of calcium imaging, synaptic stimulation, glutamate or adenosine iontophoresis and specific pharmacological agents that act on the NMDA and A1 adenosine receptors, has shown that the activation of extrasynaptic NMDA receptors increases the amplitude and duration of dendritic spikes. These effects are produced through the activation of NR2C/D receptors that increases the duration of calcium influx. By contrast, the activation of extrasynaptic A1 adenosine receptors reduces the duration of the spikes via the activation of a slow-activating potassium current. The results suggest that the release of glutamate and ATP from unknown cells, probably glia, contributes to initiation, maintenance and termination of local dendritic glutamate-mediated regenerative potentials and the associated local calcium influx.
The retina has provided examples that show how extrasynaptic release influences functional integration. A clear example is the importance of dopamine release for visual perception. Certain retinal amacrine cells synthesize both dopamine and GABA (here called 'dopaminergic amacrine cells'). Both transmitters are secreted extrasynaptically by exocytosis over the cell surface and act on neighbouring and distant neurons by volume transmission [38] . That dopamine and GABA are co-released from cell bodies was shown by measuring their release from the soma of individual amacrine cells isolated from the mouse retina: a proportion of the events of dopamine and GABA exocytosis occur simultaneously. In the retina, dopaminergic amacrine cells establish GABAergic synapses onto the 'AII' amacrine cells, which transfer rod signals to cone bipolar cells. GABA A receptors are clustered at postsynaptic terminals of the AII neurons, but dopamine receptors are not. This shows that dopamine released from synaptic terminals or extrasynaptically acts on receptors that are diffusely distributed over the surface of postsynaptic targets. The functions of dopaminergic amacrine cells are complex because of the simultaneous release of GABA as well as dopamine. Dopamine is released upon illumination; it acts through volume transmission on many types of retinal neurons and sets their gain for vision in bright light. It seems likely that GABA released by the same dopaminergic amacrine cells at their synaptic terminals blocks signals from rods that have been suddenly exposed to bright illumination. In this way, GABA would prevent the rods from entering the cone pathway and would improve the signal-to-noise ratio of colour vision. A further possibility is that extrasynaptic release of GABA by dopaminergic amacrine cells could give rise to a 'GABAergic tone'. Maintenance of a GABA concentration in the intercellular spaces may counteract the effects of the spillover of glutamate molecules from photoreceptor synapses and prevent crosstalk between OFF-and ON-pathways in the crowded environment of the inner plexiform layer.
The effects of extrasynaptic transmission go beyond the regulation of electrical responses of neurons; they also include the regulation of the activity of glia, blood vessels and muscle. Activity of nerve cells, irrespective of their transmitters, depolarizes glial cells, which in turn generate a local increase in blood flow just where it is most needed. Again, in the retina, ganglion cells, which provide the output from the retina, are inhibited by the release of ATP from Mü ller cells, the main type of retinal glial cell [39] . Of particular interest is that retinal glial cells release vasoactive agents as well as ATP. These serve to regulate local blood flow to the central nervous system, directing it to regions of electrical activity. Thus, calcium signals in glial cells cause the release of vasoactive metabolites of arachidonic acid (including prostaglandin E 2 and epoxyeicosatrienoic acids) that dilate retinal blood vessels. This accounts for the phenomenon that stimulation of the rstb.royalsocietypublishing.org Phil. Trans. R. Soc. B 370: 20140181 retina with flickering light causes retinal blood vessels to dilate, resulting in a local increase in blood flow. In addition, tonic release of ATP from retinal glial cells stimulates P2X1 receptors on vascular smooth muscle cells. Tonic activation of these muscle cells is principally responsible for generating tone in retinal blood vessels. Therefore, activity of nerve cells, irrespective of their transmitters, depolarizes glial cells (by potassium liberation), which in turn generates a local increase in blood flow just where it is most needed. A function for glial cells that had been suggested many years ago [40] has now been shown to be of crucial importance.
(d) Extrasynaptic transmitter release and disease
In Parkinson's disease, the loss of dopaminergic neurons of the substantia nigra compacta causes the development of distinctive a-synuclein (a-syn) inclusions in nigrostriatal projections, in addition to decreasing the concentration of dopamine in the striatum [41] . The a-syn inclusions can serve as a pathological measure of the severity of the disease. New evidence suggests that the a-syn inclusions play a role in synaptic transmission and in the physiological actions of dopaminergic neurons. In toxic and transgenic a-syn models of Parkinson's disease, studies have been made of the effect of various levels of dopamine denervation on synaptic plasticity in striatal neurons and interneurons. An intriguing hypothesis is that dyskinesias following treatment might arise from alterations in long-term potentiation. In experimental Parkinson's disease, the dyskinesias are correlated with changes in the reversal of long-term potentiation.
Another example of extrasynaptic release that bears on Parkinson's disease and dyskinesias is that of nitric oxide (NO). As a gas, NO is not released by exocytosis. Instead, it diffuses out of the cells that produce it to activate neighbouring targets via volume transmission. A prominent disorder in patients suffering from Parkinson's disease is a dyskinesia that arises as a consequence of treatment by L-DOPA. The mechanism for the production of the uncoordinated, involuntary, movements that follow long-term treatment with L-DOPA are not yet fully understood. New evidence [42] suggests that extrasynaptic release of NO plays a part. The gas is synthesized by NO synthase (NOS), which is co-localized with the enzyme responsible for the production of dopamine in cell bodies of the nigrostriatal pathway. In the mouse, inhibition of NOS blocks dyskinesia that follows treatment with L-DOPA. Clinical trials are now in progress to test whether blockage of NO synthesis can alleviate dyskinesia in patients suffering from Parkinson's disease who are being treated with L-DOPA.
Small soluble oligomers of amyloidogenic proteins have been implicated in Alzheimer's and Parkinson's diseases [43] . However, the pathway leading to toxicity remains obscure. Most of the mechanisms that have been proposed are generic in nature, and they do not directly explain the neuron-typespecific lesions observed in many of these diseases. For example, dysfunction of cholinergic and serotonergic cells is prominent in the initial stage of Alzheimer's disease, whereas dopaminergic cells are lost in Parkinson's disease. New evidence indicates that components of the neurotransmitter vesicular machinery are indeed intermediaries in the process of amyloid-induced toxicity. The toxic oligomers may act on the neurotransmitter synaptic release machinery: vesicular traffic, size of the storage and recycling vesicle pools, endocytosis and vesicular content. Direct multiphoton imaging of serotonin and dopamine has been used to measure quantitatively the effect of the toxic amyloids on the intracellular vesicles. These studies could provide a connection to the neuron-type specificity observed in the neurodegenerative diseases. The vesicular machinery provides both a new assay for monitoring disease progression, and a new target for developing pharmacological agents for treating diseases of the nervous system.
(e) Concluding remarks
This collection of papers points the way for the generation of new data and hypotheses for the mechanisms and significance of an essential form of signalling in the nervous system, namely the release of chemical transmitters and other key molecules from cell bodies, dendrites and axons of neurons, and from glial cells. At first glance, the principal differences from synaptic transmission are the slower time course and wider distribution of targets. However, the detailed cellular studies shown here demonstrate that multiple steps must be accomplished for electrical stimulation to evoke somatic or dendritic exocytosis. Each of these steps is a potential regulatory mechanism. An important feature of this regulation is that the extracellular concentrations of the signalling molecules modulate neuronal functions at many levels, from channel populations to higher integrative functions such as mood states and diseases. In addition to the signalling molecules discussed here, many others act extrasynaptically. It is therefore not surprising that more than one and maybe many signalling molecules act simultaneously on the same target cell. This suggests that the enormous complexity and diversity of responses of the nervous system to a given stimulus may be part of a large catalogue of potential responses. The list of extrasynaptic mechanisms provided in this issue of Philosophical Transactions is incomplete and one can expect new surprises. An unexpected finding has been made at sensory nerve endings. In muscle spindles the sensory nerve endings release glutamate, which acts back on the nerve terminals to raise their electrical excitability during a stretch [44, 45] .
It is a sobering thought that knowledge of the circuitry of the brain will probably not on its own explain how it works. For example, without knowing the detailed connections of the cells in the retina, one cannot begin to guess how light is transduced to give rise to action potentials in the optic nerve. But the anatomy on its own, and even the properties of the synapses, do not reveal the essential role of extrasynatptically released dopamine in the retina or in other areas of the nervous system. A further comparison is between extrasynaptic release and glandular secretion. This comparison contributes to our knowledge of basic mechanisms of communication; it also contributes to our understanding of how three complementary communication systems act in concert to regulate integrated physiology. Fast synaptic transmission allows rapid responses or long-term changes in efficacy. In parallel, extrasynaptic exocytosis modulates such responses over intermediate-and long-term periods, and the endocrine system links the nervous system to the rest of the body. Another player in extrasynaptic exocytosis is glia. By capturing and releasing transmitters and other molecules, glial cells link the electrical activity of neurons with the physiology of other cell types in the nervous system. However, the mechanism by which glia direct and release transmitters onto their targets is still poorly understood.
rstb.royalsocietypublishing.org Phil. Trans. R. Soc. B 370: 20140181
Hence, the physiological effects of extrasynaptic transmission contribute to regulate the responses of neural circuits directly by changing the neuronal and glial properties; they also influence the energy and oxygen availability through the regulation of blood flow. It is therefore not surprising that dysfunctions of extrasynaptic release may contribute to different diseases.
It is one of the ironies of science that the first inklings of chemically mediated synaptic transmission were postulated (at a time when all synaptic transmission was supposed to be electrical in nature) through studies of the release of adrenaline by the adrenal medulla and of acetylcholine from the vagus nerve to the heart. Both constitute extrasynaptic release.
